奥泰生物 (688606.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务摘要(单季度)(奥泰生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
单季度财务指标:
 单季度每股收益(元) 1.001.001.001.00--1.00
 单季度销售毛利率(%) 57.0060.0050.0051.0051.0037.0053.00
 单季度销售净利率(%) 33.0040.0022.0041.0018.0020.0017.00
 单季度净资产收益率ROE(%) 2.002.001.002.001.001.001.00
 单季度总资产净利率ROA(%) 2.002.001.002.001.001.001.00
单季度财务摘要:
 单季度营业总收入(元) 221,522,105.00196,582,471.00199,920,896.00194,758,300.00172,091,296.00151,711,958.00236,135,335.00
 单季度营业总成本(元) 152,175,504.00128,790,068.00144,138,320.00154,229,802.00131,943,849.00126,981,655.00178,928,269.00
 单季度营业收入(元) 221,522,105.00196,582,471.00199,920,896.00194,758,300.00172,091,296.00151,711,958.00236,135,335.00
 单季度营业利润(元) 84,732,829.0094,720,686.0047,328,962.0082,479,357.0038,025,983.0044,821,152.0046,254,816.00
 单季度利润总额(元) 84,169,079.0091,991,365.0047,157,267.0082,475,506.0037,700,790.0031,206,905.0046,055,549.00
 单季度净利润(元) 74,010,581.0078,890,250.0044,644,330.0079,034,288.0030,419,466.0030,490,725.0040,336,129.00
 单季度归属母公司股东的净利润(元) 73,646,996.0079,090,496.0044,788,914.0079,010,495.0030,383,844.0030,649,350.0040,532,501.00
 单季度经营活动产生的现金流量(元) 88,965,732.0063,670,698.0039,081,463.00108,793,566.0035,553,775.0058,092,075.00-177,675,721.00
 单季度投资活动产生的现金流量(元) 207,399,182.00-282,350,438.00-76,251,368.00-194,301,281.00-352,753,744.00326,390,021.0079,996,945.00
 单季度筹资活动产生的现金流量(元) -65,625,493.00-50,467,583.00-39,515,312.00-274,752.00-20,884,614.00-529,335,741.00-8,295,694.00
 单季度现金及现金等价物净增加(元) 223,275,756.00-267,165,060.00-76,639,100.00-88,594,742.00-343,451,918.00-120,856,554.00-112,314,334.00

前瞻产业研究院